Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Trump Presidency Could Cause Issues for Climate Change Policy and Businesses Embracing ESG
-
Strengthening Dollar, Upcoming Fed Policy Announcement Cause Gold price to Slide
-
EV Industry Awaits Musk’s Role in Influencing US EV Policy
-
New AI System Could Simplify Screening for Diabetes, High Blood Pressure
-
Notice of Public Webcast for Eastman Circular Economy Deep Dive, November 21, 2024
-
Toll Brothers Announces New Luxury Home Community Now Open in Flower Mound, Texas
-
Results of Annual General Meeting
-
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
-
Nayax to Showcase Tigapo’s Innovative Interactive Amusement Solution at IAAPA Expo 2024, Now with AI Chatbot for Operators
-
Bedsure's Early Black Friday: Unbeatable Deals on Cozy Essentials
-
5WPR Selected as Agency of Record for Premium Non-Alcoholic Beer, BERO
-
Fountain Life Adds Exclusive, Concierge Care Services to its APEX Premium Longevity Membership
-
Duke Energy Foundation helps make Florida's natural resources more resilient with $285,000 in grants
-
Reach Completes Phase II of Future Force Energy Campaign with U.S. Air Force, Demonstrating World’s First Wireless Power Relays
-
Kaizen Bioscience Preparing Lead Asset for NDA Submission in 2025
-
Lushair Becomes The World's First AI-Driven Hair Care Device
-
Gumart: Empowering Digital Transactions with Web3 and Revolutionary Partnerships
-
Meet Dr. Hassan Elhais: A Pillar of Legal Expertise for Expats in the UAE
-
Atlantic Restoration Rebrands to "HOUZPITAL," Redefining Property Damage Restoration with Smart Home Solutions and Environmental Excellence
-
Jawnt unveils industry-first mapping tool for commuter benefits
-
2024 ASEAN-China GBA Economic Cooperation (Qianhai) Forum Kicks Off
-
BrokerTech Ventures Announces Strategic Partnership With Instech.IE to Drive Global Innovation
-
CMS Confirms Coverage of Kerecis Fish-Skin Products by Medicare
-
Sparian Biosciences Awarded $19.5 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-226 for Opiate Use Disorder/ Opiate Withdrawal Syndrome Through Phase 1 Clinical Development
-
Sparian Biosciences Awarded $19.5 Million Five-Year NIH/ NIDA Grant to Fund Development of SBS-226 for Opiate Use Disorder/ Opiate Withdrawal Syndrome Through Phase 1 Clinical Development
-
Discuss’ Winter Release Brings ‘Never Before Seen’ Innovation That Will Reshape Market Insights For Global Organizations
-
Burger King℠ Foundation Opens Scholars Program Applications for 2025 – 2026 Academic Year – Apply Now!
-
Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
-
USAHS Rounds Out Exceptional Austin Leadership Team to Tackle Healthcare Worker Shortage
-
Fernmoor Starts New Apartment Community at The Shops @ Rockvale with Demolition
-
Cetera Welcomes Eglin Federal Credit Union
-
Boehringer Ingelheim Commits to Veeva Vault CRM
-
Dayton Nurseries and 20-Acre Property for Sale
-
SwiftConnect Raises $37 Million of Financing in Series B Round
-
Avantax Welcomes Independent Financial Advisor Carolyn Bare, Founder of Trust Matters Financial
-
Eaton and Treehouse Form Strategic Collaboration To Accelerate Mass Adoption of EV Charging and Electrification in U.S. Homes
-
U.S. Bank Helps Build 30 Habitat for Humanity Homes in St. Paul
-
Eastman and UPM Partner to Develop a Novel Paper-Based Food Packaging Solution
-
YKK Unveils Innovative Zipper to Boost Garment Recycling
-
Northern Trust to Participate in Goldman Sachs 2024 US Financial Services Conference
-
At HARMAN, Inspiration in Every Tradition
-
AELF Closes 737 Financing With Nedbank
-
UES Ranks #81 on the ENR 2024 Top 200 Environmental Firms Survey
-
Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024
-
Utah State University Analysis on Diestel Regenerative Turkeys Indicates that Diestel Birds Raised with Regenerative Farming Practices Have Improved Nutritional Profiles over Conventionally Raised Tur
-
Agora Launches Smart Questionnaire to Simplify the Onboarding and Subscription Process For Real Estate Investors
-
Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic Sclerosis
-
AM Best Affirms Credit Ratings of Alliance Insurance (PSC)
-
Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
-
New Home Lots Significantly Undersupplied in Most Major Metropolitan Areas
